Stem Cell Transplantation Clinical Trial
Official title:
Inflammatory Response to Paramyxovirus Infection in an Ex-vivo Model of Bronchial Epithelial Cells in Allogeneic Hematopoietic Stem Cell Recipients
Introduction. Chronic graft-versus-host-disease (GVHD) is the main late noninfectious
complication after allogeneic hematopoietic stem cell transplantation (HSCT) that can affect
several organs. Bronchiolitis obliterans syndrome (BOS) is recognized as pulmonary chronic
GVHD. A diagnosis of a lower respiratory tract infection in the first 100 days following
transplant has been associated to the development of BOS. One hypothesis is that the first
stage driving to BOS is a previous aggression of bronchial epithelial cells by various
factors such as chemotherapy and radiotherapy. Thereafter, data suggest that viral
infections, in particular Parainfluenza viruses could be a trigger for BOS. The alloimmune
reaction activated by the respiratory virus could lead to the fibrosis process. Our
hypothesis is that the bronchial epithelium of allogeneic HSCT recipients has phenotypic
specificities that are associated with a specific response to the viral respiratory
infections (in particular paramyxovirus) leading to the development of BOS.
Main objective. To characterize and compare the inflammatory response after infection with
Parainfluenza 3 virus in an ex-vivo model of bronchial epithelial cells obtained from
allogeneic HSCT recipients and controls.
Objective secondary. To characterize the phenotypic specificities of allogeneic HSCT
recipients' bronchial epithelium.
Methodology, and experimental plan. Prospective, monocentric research. Bronchial biopsies
obtained from patients, will be completely differentiated after 21 days of culture.
Epithelial cells will be infected by the virus strain Parainfluenza 3. Transcriptome of the
cells from both allogeneic HSCT patients and controls, infected and non-infected will be
analyzed 48 hours after infection.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03918343 -
Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation
|
N/A | |
Not yet recruiting |
NCT05438823 -
Technology Supported Education Program Based on Human Care Theory
|
N/A | |
Not yet recruiting |
NCT02193399 -
Physiotherapy in Hematopoietic Stem Cell Transplantation
|
N/A | |
Withdrawn |
NCT00972101 -
Infusion of Expanded Cord Blood T Cells
|
Phase 1 | |
Completed |
NCT05421299 -
A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate
|
||
Completed |
NCT04976933 -
Post-HSCT Medication Adherence mHealth App
|
||
Completed |
NCT04798495 -
Feasibility of a Rehabilitation Programme Targeted Patients Treated With Non-myeloablative Stem Cell Transplantation
|
N/A | |
Completed |
NCT00612274 -
Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation
|
Phase 0 | |
Active, not recruiting |
NCT04511130 -
Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant
|
Phase 2 | |
Recruiting |
NCT05968963 -
Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation
|
N/A | |
Recruiting |
NCT02940093 -
Pipeline Integrating Gut Metagenome Data, Host Immunogenetic Characteristics and Clinical Gut Inflammatory Biomarkers
|
N/A | |
Not yet recruiting |
NCT06077734 -
Muscle Stem Cell Quality in Atrophy
|
||
Terminated |
NCT00587990 -
Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS)
|
Phase 1/Phase 2 | |
Terminated |
NCT00597441 -
Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation
|
Phase 1 | |
Recruiting |
NCT00884338 -
Cognitive Function After Stem Cell Transplantation
|
Phase 3 | |
Completed |
NCT00284713 -
Progenitor Cell Therapy in Dilative Cardiomyopathy
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00062543 -
Hepatic Artery Infusion of CD34+ Cells
|
Phase 1 | |
Completed |
NCT00781170 -
Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma
|
Phase 2 | |
Recruiting |
NCT03364257 -
iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients
|
||
Enrolling by invitation |
NCT06134297 -
Adherence, Viability, Clinical Evolution and Therapeutic Efficacy in Patients Undergoing Bone Marrow Transplantation
|
N/A |